The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors (Q37410764)
Jump to navigation
Jump to search
scientific article published on 24 August 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors |
scientific article published on 24 August 2009 |
Statements
1 reference
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors (English)
1 reference
1 reference
Mark Watson
1 reference
Anne Roulston
1 reference
Laurent Bélec
1 reference
Xavier Billot
1 reference
Richard Marcellus
1 reference
Dominique Bédard
1 reference
Cynthia Bernier
1 reference
Stéphane Branchaud
1 reference
Helen Chan
1 reference
Kenza Dairi
1 reference
Karine Gilbert
1 reference
Daniel Goulet
1 reference
Michel-Olivier Gratton
1 reference
Henady Isakau
1 reference
Anne Jang
1 reference
Abdelkrim Khadir
1 reference
Elizabeth Koch
1 reference
Manon Lavoie
1 reference
Michael Lawless
1 reference
Mai Nguyen
1 reference
Denis Paquette
1 reference
Emilie Turcotte
1 reference
Alvin Berger
1 reference
Gordon C Shore
1 reference
Pierre Beauparlant
1 reference
24 August 2009
1 reference
1 reference
5872-5888
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference